查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1477962

神经外科市场：依地区：全球产业分析、规模、占有率、成长、趋势，2024-2032 年预测

Neurosurgery Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 300 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究提供了一份全面的报告，全面分析了神经外科市场并详细介绍了其全球前景。这份详细的出版物提供了有关市场动态、趋势、机会和课题的宝贵见解，并对其结构进行了全面概述。在独家数据和统计的支持下，预测 2024 年至 2032 年神经外科市场的预期成长轨迹。

预计到2024年底，神经外科市场的全球收入将达到43.7亿美元，以4.5%的复合年增长率稳定成长。预计到 2032 年底，这一轨迹将使市场规模成长至约 79 亿美元。

重要见解

  • 神经外科市场规模（2024年）：43.7亿美元
  • 预计市值（2032 年）：79 亿美元
  • 全球市场成长率（2024-2032年复合年增长率）：4.5%

神经外科市场：调查范围

神经外科包括旨在治疗影响神经系统（包括大脑、脊髓和周围神经）疾病的外科手术。神经外科市场包括用于诊断和治疗神经系统疾病的各种手术技术、设备和技术。其主要业务包括神经刺激器、神经内视镜系统、神经外科导航系统和神经介入设备。

市场成长的推动因素包括神经系统疾病盛行率的增加、手术技术和技术的进步以及微创手术需求的增加。此外，新兴国家医疗费用的上涨、老年人口的增加以及医疗基础设施的改善也促进了市场的扩张。

市场成长动力：

中风、癫痫、巴金森氏症和脑肿瘤等神经系统疾病的盛行率增加

神经影像技术的进步实现了准确的诊断和治疗计划

更多采用微创神经外科手术，减少患者不适并缩短復原时间

对治疗慢性疼痛、运动障碍和精神疾病的神经刺激设备的需求不断增长

扩大发展中地区的医疗基础设施和专业神经外科中心的可用性

市场限制：

神经外科手术和设备的高昂成本限制了低收入地区的使用。

设备审批的严格监管要求延长了上市时间并增加了开发成本。

缺乏熟练的神经外科医生和神经科医生，特别是在农村和服务不足的地区。

对某些神经外科技术和设备的安全性和有效性的担忧导致患者和医疗保健提供者犹豫不决。

市场机会：

神经外科在精神疾病、运动障碍和慢性疼痛疾病治疗的新应用。

人工智慧 (AI) 和机器学习 (ML) 技术在神经影像和手术导航系统中的集成

产业利益相关者、研究机构和医疗保健提供者之间的合作，开发创新的神经外科解决方案。

远距医疗和远端监控服务的扩展改善了偏远和服务不足地区获得神经外科专家的机会

本报告解决的关键问题

  • 推动全球神经外科市场成长的关键因素是什么？
  • 哪些神经外科技术和设备最受欢迎且采用率最高？
  • 技术进步如何改变神经外科市场的竞争格局？
  • 谁是对神经外科市场做出贡献的主要公司？ 他们采取什么策略来维持市场地位？
  • 全球神经外科市场有哪些新趋势和未来前景？

目录

第一章执行摘要

第二章市场概况

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含什么和不包含什么

第 3 章主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第 4 章 关键成功因素

  • 重大疾病流行病学
  • 产品采用/使用分析
  • 产品 USP/特点
  • 厂商主要促销策略
  • 波特的分析
  • PESTLE分析
  • 价值链分析

第五章市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 市场动态

第 6 章 COVID-19 危机分析

  • COVID-19 与影响分析
    • 依产品划分的收入
    • 最终用户收入
    • 国家收入
  • 2024年市场情景

第七章 全球神经外科市场需求（数量及规模）

  • 过去的市场（金额）分析，2019-2023
  • 当前和未来市场（价值）预测，2024-2032

第八章全球神经外科市场分析：依产品

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2032
    • 神经介入装置
      • 神经血管栓塞装置
        • 栓塞弹簧圈
        • 液体栓塞系统
        • 血流导流支架
        • 动脉瘤夹
      • 神经血管线圈辅助装置
        • 线圈辅助支架
        • 线圈辅助球囊
      • 神经血管取栓装置
        • 支架取出装置
        • 抽吸检索器
      • 微导丝
      • 微导管
      • 支撑导管
      • 颅内支架
    • 神经内视镜
      • 柔性神经内视镜
      • 硬质神经内视镜
    • 神经外科钻孔机
      • 气动神经外科钻
      • 电动神经外科钻
    • 放射外科系统
      • 线性加速放射外科系统
      • 伽玛刀放射治疗系统
    • 硬脑膜替代品
      • 生物硬脑膜替代品
      • 合成硬脑膜替代品
    • 神经外科消融装置
      • MRI导引聚焦超音波系统
      • MRI导引雷射治疗系统
      • MRI导引射频消融系统
    • 神经外科器械
      • 组织牵开器
      • 钳子
      • 头架
      • 子宫颈电镀系统
      • 穿孔器
  • 产品市场吸引力分析

第九章全球神经外科市场分析：依最终用户分类

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2032
    • 医院
    • 门诊手术中心
    • 专业神经学研究所
  • 最终用户的市场吸引力分析

第10章全球神经外科市场分析：依地区

  • 介绍
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2032
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲 (MEA)
  • 区域市场吸引力分析

第十一章 北美神经外科市场分析

第十二章拉丁美洲神经外科市场分析

第十三章欧洲神经外科市场分析

第14章南亚和太平洋地区神经外科市场分析

第十五章东亚神经外科市场分析

第十六章大洋洲神经外科市场分析

第十七章中东与非洲神经外科市场分析

第18章市场结构分析

  • 依公司层级进行市场分析
  • 主要参与者的市场占有率分析
  • 市场存在分析

第 19 章 竞争分析

  • 比赛仪表板
  • 竞争标桿
  • 衝突详情
    • Stryker Corp.
    • B. Braun Melsungen AG
    • Medtronic plc
    • DePuy Synthes
    • Boston Scientific
    • Terumo Corporation
    • KARL STORZ GmbH &Co KG
    • Integra LifeSciences
    • Penumbra Inc
    • Adeor Medical AG
    • Elekta
    • Clarus Medical
    • MACHIDA ENDOSCOPE CO., LTD.

第 20 章使用的假设和首字母缩略词

第21章研究方法论

简介目录
Product Code: PMRREP4790

Persistence Market Research has conducted a thorough analysis of the Neurosurgery Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Neurosurgery Market spanning from 2024 to 2032.

The neurosurgery market's global revenue stood at US$ 4.37 billion by the close of 2024, projected to grow steadily with a compound annual growth rate (CAGR) of 4.5%. This trajectory is expected to propel the market to approximately US$ 7.9 billion by the conclusion of 2032.

Key Insights:

  • Neurosurgery Market Size (2024): US$ 4.37 billion
  • Projected Market Value (2032): US$ 7.9 billion
  • Global Market Growth Rate (CAGR 2024-2032): 4.5%

Neurosurgery Market - Report Scope:

Neurosurgery involves surgical procedures aimed at treating conditions affecting the nervous system, including the brain, spinal cord, and peripheral nerves. The neurosurgery market encompasses a wide range of surgical techniques, devices, and technologies used in the diagnosis and treatment of neurological disorders. Key segments include neurostimulation devices, neuroendoscopy systems, neurosurgical navigation systems, and neurointerventional devices.

Market growth is driven by factors such as the increasing prevalence of neurological disorders, advancements in surgical techniques and technologies, and growing demand for minimally invasive procedures. Additionally, rising healthcare expenditures, expanding geriatric population, and improving healthcare infrastructure in emerging economies contribute to market expansion.

Market Growth Drivers:

Increasing prevalence of neurological disorders such as stroke, epilepsy, Parkinson's disease, and brain tumors

Advancements in neuroimaging techniques, enabling accurate diagnosis and treatment planning

Growing adoption of minimally invasive neurosurgical procedures, reducing patient discomfort and recovery times

Rising demand for neurostimulation devices for the management of chronic pain, movement disorders, and psychiatric conditions

Expansion of healthcare infrastructure and the availability of specialized neurosurgical centers in developing regions

Market Restraints:

High cost associated with neurosurgical procedures and devices, limiting access in low-income regions

Stringent regulatory requirements for device approval, leading to extended time-to-market and higher development costs

Lack of skilled neurosurgeons and neurologists, particularly in rural and underserved areas

Concerns regarding the safety and efficacy of certain neurosurgical techniques and devices, leading to hesitancy among patients and healthcare providers

Market Opportunities:

Emerging applications of neurosurgery in the treatment of psychiatric disorders, movement disorders, and chronic pain conditions

Integration of artificial intelligence (AI) and machine learning (ML) technologies in neuroimaging and surgical navigation systems

Collaboration between industry stakeholders, research institutions, and healthcare providers to develop innovative neurosurgical solutions

Expansion of telemedicine and remote monitoring services, improving access to neurosurgical expertise in remote and underserved areas

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the neurosurgery market globally?
  • Which neurosurgical techniques and devices are experiencing the highest demand and adoption rates?
  • How are technological advancements reshaping the competitive landscape of the neurosurgery market?
  • Who are the key players contributing to the neurosurgery market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global neurosurgery market?

Competitive Intelligence and Business Strategy:

Leading players in the global neurosurgery market, including Medtronic plc, Stryker Corporation, Johnson & Johnson, and Integra LifeSciences Holdings Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced neurosurgical devices and technologies, catering to the evolving needs of patients and healthcare providers.

Collaborations with neurology and neurosurgery centers, academic institutions, and government agencies facilitate market access and technology adoption. Moreover, emphasis on physician training, patient education, and clinical research promotes evidence-based practice and improves patient outcomes in the rapidly evolving field of neurosurgery.

Key Companies Profiled

  • B. Braun Melsungen AG
  • Medtronic plc
  • DePuy Synthes
  • Boston Scientific
  • Stryker Corp.
  • Terumo Corporation
  • KARL STORZ GmbH & Co KG
  • Integra LifeSciences
  • Penumbra Inc
  • Adeor Medical AG
  • Elekta
  • Clarus Medical
  • MACHIDA ENDOSCOPE CO., LTD.

Key Segments Covered in Neurosurgery Industry Research

Neurosurgery Market by Product:

  • Neuro Interventional Devices
  • Neuroendoscopes
  • Neurosurgical Drills
  • Radiosurgery Systems
  • Dura Substitutes
  • Neurosurgery Instruments

Neurosurgery Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Neurological Institutes

Neurosurgery Market by Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Disease Epidemiology
  • 4.2. Product Adoption / Usage Analysis
  • 4.3. Product USPs / Features
  • 4.4. Key Promotional Strategies, By Manufacturers
  • 4.5. Porter's Analysis
  • 4.6. PESTLE Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Healthcare Market GDP and Growth Outlook
    • 5.1.2. Global Assistive Devices Market Overview
    • 5.1.3. Medical Device Industry Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. GDP Growth Forecast
    • 5.2.2. Ageing Population
    • 5.2.3. Growing Prevalence of Neurologic Diseases
    • 5.2.4. Growing Healthcare Expenditure
    • 5.2.5. Shift Towards Minimally Invasive Procedures
    • 5.2.6. Growing Research Efforts
    • 5.2.7. Cost Impact
    • 5.2.8. Entries Of New Start-Up Companies In The Market
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Product
    • 6.1.2. Revenue By End User
    • 6.1.3. Revenue by Country
  • 6.2. 2024 Market Scenario

7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 8.3.1. Neuro Interventional Devices
      • 8.3.1.1. Neurovascular Embolization Devices
        • 8.3.1.1.1. Embolization Coils
        • 8.3.1.1.2. Liquid Embolic Systems
        • 8.3.1.1.3. Flow Diversion Stents
        • 8.3.1.1.4. Aneurysm Clips
      • 8.3.1.2. Neurovascular Coiling Assist Devices
        • 8.3.1.2.1. Coiling Assist Stents
        • 8.3.1.2.2. Coiling Assist Balloons
      • 8.3.1.3. Neurovascular Thrombectomy Devices
        • 8.3.1.3.1. Stent Retrievers
        • 8.3.1.3.2. Aspiration Retrievers
      • 8.3.1.4. Microguidewires
      • 8.3.1.5. Microcatheters
      • 8.3.1.6. Support Catheters
      • 8.3.1.7. Intracranial Stents
    • 8.3.2. Neuroendoscopes
      • 8.3.2.1. Flexible Neuroendoscopes
      • 8.3.2.2. Rigid Neuroendoscopes
    • 8.3.3. Neurosurgical Drills
      • 8.3.3.1. Pneumatic Neurosurgical Drills
      • 8.3.3.2. Electrical Neurosurgical Drills
    • 8.3.4. Radiosurgery Systems
      • 8.3.4.1. Linear Accelerator Radiosurgery Systems
      • 8.3.4.2. Gamma Knife Radiosurgery Systems
    • 8.3.5. Dura Substitutes
      • 8.3.5.1. Biological Dura Substitutes
      • 8.3.5.2. Synthetic Dura Substitutes
    • 8.3.6. Neurosurgical Ablation Devices
      • 8.3.6.1. MRI Guided Focused Ultrasound Systems
      • 8.3.6.2. MRI Guided Laser Therapy Systems
      • 8.3.6.3. MRI Guided RF Ablation Systems
    • 8.3.7. Neurosurgery Instruments
      • 8.3.7.1. Tissue Retractors
      • 8.3.7.2. Forceps
      • 8.3.7.3. Head Frames
      • 8.3.7.4. Cervical Plating systems
      • 8.3.7.5. Perforators
  • 8.4. Market Attractiveness Analysis By Product

9. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2032
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Specialized Neurological Institutes
  • 9.4. Market Attractiveness Analysis By End User

10. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By End User
  • 11.5. Market Trends
  • 11.6. Key Market Participants - Intensity Mapping
  • 11.7. Drivers and Restraints - Impact Analysis
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. U.S. Neurosurgery Market
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.1.2.1. By Product
        • 11.8.1.2.2. By End User
    • 11.8.2. Canada Neurosurgery Market
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.2.2.1. By Product
        • 11.8.2.2.2. By End User

12. Latin America Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Argentina
      • 12.3.1.3. Mexico
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Brazil Neurosurgery Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By End User
    • 12.8.2. Mexico Neurosurgery Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By End User
    • 12.8.3. Argentina Neurosurgery Market
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.3.2.1. By Product
        • 12.8.3.2.2. By End User

13. Europe Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. France
      • 13.3.1.3. Italy
      • 13.3.1.4. Spain
      • 13.3.1.5. UK
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Nordic Countries
      • 13.3.1.9. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Neurosurgery Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By End User
    • 13.8.2. Italy Neurosurgery Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By End User
    • 13.8.3. France Neurosurgery Market
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By End User
        • 13.8.3.2.3.
    • 13.8.4. Spain Neurosurgery Market
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Product
        • 13.8.4.2.2. By End User
    • 13.8.5. U.K. Neurosurgery Market
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Product
        • 13.8.5.2.2. By End User
    • 13.8.6. Benelux Union Neurosurgery Market
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Product
        • 13.8.6.2.2. By End User
    • 13.8.7. Nordic Countries Neurosurgery Market
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Product
        • 13.8.7.2.2. By End User
    • 13.8.8. Russia Neurosurgery Market
      • 13.8.8.1. Introduction
      • 13.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.8.2.1. By Product
        • 13.8.8.2.2. By End User

14. South Asia and Pacific Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. India
      • 14.3.1.2. Indonesia
      • 14.3.1.3. Malaysia
      • 14.3.1.4. Thailand
      • 14.3.1.5. Rest of South Asia
    • 14.3.2. By Product
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. India Neurosurgery Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By End User
    • 14.8.2. Indonesia Neurosurgery Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By End User
    • 14.8.3. Malaysia Neurosurgery Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By End User
    • 14.8.4. Thailand Neurosurgery Market
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Product
        • 14.8.4.2.2. By End User

15. East Asia Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Neurosurgery Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By End User
    • 15.8.2. Japan Neurosurgery Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By End User
    • 15.8.3. South Korea Neurosurgery Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By End User

16. Oceania Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Neurosurgery Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By End User
    • 16.8.2. New Zealand Neurosurgery Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By End User

17. Middle East and Africa Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. Israel
      • 17.3.1.4. Northern Africa
      • 17.3.1.5. South Africa
      • 17.3.1.6. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Neurosurgery Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By End User
    • 17.8.2. Turkey Neurosurgery Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By End User
    • 17.8.3. North Africa Neurosurgery Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By End User
    • 17.8.4. South Africa Neurosurgery Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Stryker Corp.
      • 19.3.1.1. .Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Key Financials
      • 19.3.1.4. SWOT Analysis
      • 19.3.1.5. Key Developments
      • 19.3.1.6. Sales Footprint
      • 19.3.1.7. Strategy Overview
        • 19.3.1.7.1. Marketing Strategy
        • 19.3.1.7.2. Product Strategy
        • 19.3.1.7.3. Channel Strategy
    • 19.3.2. B. Braun Melsungen AG
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Key Financials
      • 19.3.2.4. SWOT Analysis
      • 19.3.2.5. Key Developments
      • 19.3.2.6. Sales Footprint
      • 19.3.2.7. Strategy Overview
        • 19.3.2.7.1. Marketing Strategy
        • 19.3.2.7.2. Product Strategy
        • 19.3.2.7.3. Channel Strategy
    • 19.3.3. Medtronic plc
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Key Financials
      • 19.3.3.4. SWOT Analysis
      • 19.3.3.5. Key Developments
      • 19.3.3.6. Sales Footprint
      • 19.3.3.7. Strategy Overview
        • 19.3.3.7.1. Marketing Strategy
        • 19.3.3.7.2. Product Strategy
        • 19.3.3.7.3. Channel Strategy
    • 19.3.4. DePuy Synthes
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Key Financials
      • 19.3.4.4. SWOT Analysis
      • 19.3.4.5. Key Developments
      • 19.3.4.6. Sales Footprint
      • 19.3.4.7. Strategy Overview
        • 19.3.4.7.1. Marketing Strategy
        • 19.3.4.7.2. Product Strategy
        • 19.3.4.7.3. Channel Strategy
    • 19.3.5. Boston Scientific
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Key Financials
      • 19.3.5.4. SWOT Analysis
      • 19.3.5.5. Key Developments
      • 19.3.5.6. Sales Footprint
      • 19.3.5.7. Strategy Overview
        • 19.3.5.7.1. Marketing Strategy
        • 19.3.5.7.2. Product Strategy
        • 19.3.5.7.3. Channel Strategy
    • 19.3.6. Terumo Corporation
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Key Financials
      • 19.3.6.4. SWOT Analysis
      • 19.3.6.5. Key Developments
      • 19.3.6.6. Sales Footprint
      • 19.3.6.7. Strategy Overview
        • 19.3.6.7.1. Marketing Strategy
        • 19.3.6.7.2. Product Strategy
        • 19.3.6.7.3. Channel Strategy
    • 19.3.7. KARL STORZ GmbH & Co KG
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Key Financials
      • 19.3.7.4. SWOT Analysis
      • 19.3.7.5. Key Developments
      • 19.3.7.6. Sales Footprint
      • 19.3.7.7. Strategy Overview
        • 19.3.7.7.1. Marketing Strategy
        • 19.3.7.7.2. Product Strategy
        • 19.3.7.7.3. Channel Strategy
    • 19.3.8. Integra LifeSciences
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Key Financials
      • 19.3.8.4. SWOT Analysis
      • 19.3.8.5. Key Developments
      • 19.3.8.6. Sales Footprint
      • 19.3.8.7. Strategy Overview
        • 19.3.8.7.1. Marketing Strategy
        • 19.3.8.7.2. Product Strategy
        • 19.3.8.7.3. Channel Strategy
    • 19.3.9. Penumbra Inc
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Key Financials
      • 19.3.9.4. SWOT Analysis
      • 19.3.9.5. Key Developments
      • 19.3.9.6. Sales Footprint
      • 19.3.9.7. Strategy Overview
        • 19.3.9.7.1. Marketing Strategy
        • 19.3.9.7.2. Product Strategy
        • 19.3.9.7.3. Channel Strategy
    • 19.3.10. Adeor Medical AG
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Key Financials
      • 19.3.10.4. SWOT Analysis
      • 19.3.10.5. Key Developments
      • 19.3.10.6. Sales Footprint
      • 19.3.10.7. Strategy Overview
        • 19.3.10.7.1. Marketing Strategy
        • 19.3.10.7.2. Product Strategy
        • 19.3.10.7.3. Channel Strategy
    • 19.3.11. Elekta
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Key Financials
      • 19.3.11.4. SWOT Analysis
      • 19.3.11.5. Key Developments
      • 19.3.11.6. Sales Footprint
      • 19.3.11.7. Strategy Overview
        • 19.3.11.7.1. Marketing Strategy
        • 19.3.11.7.2. Product Strategy
        • 19.3.11.7.3. Channel Strategy
    • 19.3.12. Clarus Medical
      • 19.3.12.1. Overview
      • 19.3.12.2. Product Portfolio
      • 19.3.12.3. Key Financials
      • 19.3.12.4. SWOT Analysis
      • 19.3.12.5. Key Developments
      • 19.3.12.6. Sales Footprint
      • 19.3.12.7. Strategy Overview
        • 19.3.12.7.1. Marketing Strategy
        • 19.3.12.7.2. Product Strategy
        • 19.3.12.7.3. Channel Strategy
    • 19.3.13. MACHIDA ENDOSCOPE CO., LTD.
      • 19.3.13.1. Overview
      • 19.3.13.2. Product Portfolio
      • 19.3.13.3. Key Financials
      • 19.3.13.4. SWOT Analysis
      • 19.3.13.5. Key Developments
      • 19.3.13.6. Sales Footprint
      • 19.3.13.7. Strategy Overview
        • 19.3.13.7.1. Marketing Strategy
        • 19.3.13.7.2. Product Strategy
        • 19.3.13.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology